Effects of laparoscopic sleeve gastrectomy on level of depression and dignity in adults who attended to Shiraz Ghadir Mother and ChildSubspecialized Hospital
Not Applicable
Recruiting
- Conditions
- obesity.Obesity due to excess calories
- Registration Number
- IRCT20180523039802N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age range of 21-55 years,
BMI greater than 35,
ability to read and write and patient
agreement by submitting a written consent for participation in the research
Exclusion Criteria
Diabetes mellitus, Hypertension, Thyroid disorders
Psychosis, Mania, schizophrenia
Inability to read and write
Disagreement with the patient to participate in the research
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression. Timepoint: Before bariatric surgery and 3 to 6 months after bariatric surgery. Method of measurement: Beck Depression Inventory.;Self-esteem. Timepoint: Before bariatric surgery and 3 to 6 months after bariatric surgery. Method of measurement: 3-Rosenberg Self-Esteem Questionnaire.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link laparoscopic sleeve gastrectomy to reduced depression in obesity patients?
How does laparoscopic sleeve gastrectomy compare to standard-of-care treatments for obesity in improving mental health outcomes?
Are there specific biomarkers that predict improved dignity and depression outcomes after laparoscopic sleeve gastrectomy?
What are the potential adverse events associated with laparoscopic sleeve gastrectomy and their management strategies?
How do combination approaches of bariatric surgery with pharmacotherapy impact obesity-related depression and quality of life?